nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—ADRA1D—Amitriptyline—migraine	0.191	0.28	CbGbCtD
Alfuzosin—ADRA1B—Amitriptyline—migraine	0.139	0.204	CbGbCtD
Alfuzosin—KCNH2—Verapamil—migraine	0.129	0.188	CbGbCtD
Alfuzosin—ADRA1A—Amitriptyline—migraine	0.11	0.161	CbGbCtD
Alfuzosin—CYP3A4—Propranolol—migraine	0.028	0.0411	CbGbCtD
Alfuzosin—CYP3A4—Amitriptyline—migraine	0.0242	0.0355	CbGbCtD
Alfuzosin—CYP3A4—Valproic Acid—migraine	0.0221	0.0324	CbGbCtD
Alfuzosin—CYP3A4—Topiramate—migraine	0.0199	0.0292	CbGbCtD
Alfuzosin—CYP3A4—Verapamil—migraine	0.0192	0.0282	CbGbCtD
Alfuzosin—Prazosin—HTR1D—migraine	0.00442	0.68	CrCbGaD
Alfuzosin—Prazosin—HTR1A—migraine	0.00207	0.319	CrCbGaD
Alfuzosin—Pruritus—Amitriptyline—migraine	0.000529	0.00266	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Propranolol—migraine	0.000526	0.00265	CcSEcCtD
Alfuzosin—Fatigue—Propranolol—migraine	0.000525	0.00264	CcSEcCtD
Alfuzosin—Hypotension—Verapamil—migraine	0.000524	0.00264	CcSEcCtD
Alfuzosin—Eye disorder—Valproic Acid—migraine	0.000523	0.00263	CcSEcCtD
Alfuzosin—Pain—Propranolol—migraine	0.000521	0.00262	CcSEcCtD
Alfuzosin—Constipation—Propranolol—migraine	0.000521	0.00262	CcSEcCtD
Alfuzosin—Sinusitis—Timolol—migraine	0.00052	0.00262	CcSEcCtD
Alfuzosin—Infestation NOS—Gabapentin—migraine	0.000516	0.0026	CcSEcCtD
Alfuzosin—Infestation—Gabapentin—migraine	0.000516	0.0026	CcSEcCtD
Alfuzosin—Drowsiness—Gabapentin—migraine	0.000516	0.0026	CcSEcCtD
Alfuzosin—Abdominal pain upper—Topiramate—migraine	0.000515	0.00259	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Topiramate—migraine	0.000515	0.00259	CcSEcCtD
Alfuzosin—Diarrhoea—Amitriptyline—migraine	0.000512	0.00258	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Verapamil—migraine	0.000511	0.00257	CcSEcCtD
Alfuzosin—Breast disorder—Topiramate—migraine	0.000509	0.00256	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Topiramate—migraine	0.000508	0.00256	CcSEcCtD
Alfuzosin—Angiopathy—Valproic Acid—migraine	0.000507	0.00255	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Gabapentin—migraine	0.000506	0.00255	CcSEcCtD
Alfuzosin—Mediastinal disorder—Valproic Acid—migraine	0.000504	0.00254	CcSEcCtD
Alfuzosin—Jaundice—Gabapentin—migraine	0.000503	0.00253	CcSEcCtD
Alfuzosin—Rhinitis—Timolol—migraine	0.000499	0.00251	CcSEcCtD
Alfuzosin—Somnolence—Verapamil—migraine	0.000498	0.00251	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Propranolol—migraine	0.000498	0.00251	CcSEcCtD
Alfuzosin—Sweating—Gabapentin—migraine	0.000495	0.00249	CcSEcCtD
Alfuzosin—Dizziness—Amitriptyline—migraine	0.000495	0.00249	CcSEcCtD
Alfuzosin—Dyspepsia—Verapamil—migraine	0.000493	0.00248	CcSEcCtD
Alfuzosin—Mental disorder—Valproic Acid—migraine	0.00049	0.00247	CcSEcCtD
Alfuzosin—Connective tissue disorder—Timolol—migraine	0.000489	0.00246	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Gabapentin—migraine	0.000488	0.00246	CcSEcCtD
Alfuzosin—Sinusitis—Gabapentin—migraine	0.000484	0.00244	CcSEcCtD
Alfuzosin—Urticaria—Propranolol—migraine	0.000484	0.00244	CcSEcCtD
Alfuzosin—Fatigue—Verapamil—migraine	0.000483	0.00243	CcSEcCtD
Alfuzosin—Abdominal pain—Propranolol—migraine	0.000482	0.00242	CcSEcCtD
Alfuzosin—Pain—Verapamil—migraine	0.000479	0.00241	CcSEcCtD
Alfuzosin—Constipation—Verapamil—migraine	0.000479	0.00241	CcSEcCtD
Alfuzosin—Vomiting—Amitriptyline—migraine	0.000476	0.00239	CcSEcCtD
Alfuzosin—Angina pectoris—Topiramate—migraine	0.000475	0.00239	CcSEcCtD
Alfuzosin—Rash—Amitriptyline—migraine	0.000472	0.00237	CcSEcCtD
Alfuzosin—Dermatitis—Amitriptyline—migraine	0.000471	0.00237	CcSEcCtD
Alfuzosin—Back pain—Valproic Acid—migraine	0.000471	0.00237	CcSEcCtD
Alfuzosin—Headache—Amitriptyline—migraine	0.000469	0.00236	CcSEcCtD
Alfuzosin—Bronchitis—Topiramate—migraine	0.000469	0.00236	CcSEcCtD
Alfuzosin—Eye disorder—Timolol—migraine	0.000465	0.00234	CcSEcCtD
Alfuzosin—Rhinitis—Gabapentin—migraine	0.000465	0.00234	CcSEcCtD
Alfuzosin—Cardiac disorder—Timolol—migraine	0.000462	0.00233	CcSEcCtD
Alfuzosin—Feeling abnormal—Verapamil—migraine	0.000462	0.00232	CcSEcCtD
Alfuzosin—Pharyngitis—Gabapentin—migraine	0.00046	0.00232	CcSEcCtD
Alfuzosin—Urinary tract disorder—Gabapentin—migraine	0.000458	0.0023	CcSEcCtD
Alfuzosin—Connective tissue disorder—Gabapentin—migraine	0.000456	0.00229	CcSEcCtD
Alfuzosin—Urethral disorder—Gabapentin—migraine	0.000454	0.00229	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Topiramate—migraine	0.000453	0.00228	CcSEcCtD
Alfuzosin—Ill-defined disorder—Valproic Acid—migraine	0.000452	0.00227	CcSEcCtD
Alfuzosin—Angiopathy—Timolol—migraine	0.000452	0.00227	CcSEcCtD
Alfuzosin—Erectile dysfunction—Topiramate—migraine	0.000449	0.00226	CcSEcCtD
Alfuzosin—Mediastinal disorder—Timolol—migraine	0.000449	0.00226	CcSEcCtD
Alfuzosin—Urticaria—Verapamil—migraine	0.000445	0.00224	CcSEcCtD
Alfuzosin—Angioedema—Valproic Acid—migraine	0.000445	0.00224	CcSEcCtD
Alfuzosin—Nausea—Amitriptyline—migraine	0.000444	0.00224	CcSEcCtD
Alfuzosin—Malaise—Valproic Acid—migraine	0.000439	0.00221	CcSEcCtD
Alfuzosin—Vertigo—Valproic Acid—migraine	0.000437	0.0022	CcSEcCtD
Alfuzosin—Asthenia—Propranolol—migraine	0.000437	0.0022	CcSEcCtD
Alfuzosin—Mental disorder—Timolol—migraine	0.000436	0.0022	CcSEcCtD
Alfuzosin—Infestation NOS—Topiramate—migraine	0.000434	0.00219	CcSEcCtD
Alfuzosin—Infestation—Topiramate—migraine	0.000434	0.00219	CcSEcCtD
Alfuzosin—Eye disorder—Gabapentin—migraine	0.000433	0.00218	CcSEcCtD
Alfuzosin—Cardiac disorder—Gabapentin—migraine	0.00043	0.00217	CcSEcCtD
Alfuzosin—Palpitations—Valproic Acid—migraine	0.00043	0.00217	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Topiramate—migraine	0.000426	0.00214	CcSEcCtD
Alfuzosin—Mediastinal disorder—Gabapentin—migraine	0.000418	0.0021	CcSEcCtD
Alfuzosin—Diarrhoea—Propranolol—migraine	0.000417	0.0021	CcSEcCtD
Alfuzosin—Arthralgia—Valproic Acid—migraine	0.000414	0.00209	CcSEcCtD
Alfuzosin—Chest pain—Valproic Acid—migraine	0.000414	0.00209	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000412	0.00207	CcSEcCtD
Alfuzosin—Discomfort—Valproic Acid—migraine	0.000409	0.00206	CcSEcCtD
Alfuzosin—Sinusitis—Topiramate—migraine	0.000408	0.00205	CcSEcCtD
Alfuzosin—Mental disorder—Gabapentin—migraine	0.000406	0.00204	CcSEcCtD
Alfuzosin—Dry mouth—Valproic Acid—migraine	0.000405	0.00204	CcSEcCtD
Alfuzosin—Dizziness—Propranolol—migraine	0.000403	0.00203	CcSEcCtD
Alfuzosin—Asthenia—Verapamil—migraine	0.000402	0.00202	CcSEcCtD
Alfuzosin—Oedema—Valproic Acid—migraine	0.000397	0.002	CcSEcCtD
Alfuzosin—Pruritus—Verapamil—migraine	0.000396	0.002	CcSEcCtD
Alfuzosin—Angioedema—Timolol—migraine	0.000396	0.00199	CcSEcCtD
Alfuzosin—Infection—Valproic Acid—migraine	0.000395	0.00199	CcSEcCtD
Alfuzosin—Rhinitis—Topiramate—migraine	0.000391	0.00197	CcSEcCtD
Alfuzosin—Back pain—Gabapentin—migraine	0.00039	0.00197	CcSEcCtD
Alfuzosin—Nervous system disorder—Valproic Acid—migraine	0.00039	0.00196	CcSEcCtD
Alfuzosin—Vertigo—Timolol—migraine	0.000389	0.00196	CcSEcCtD
Alfuzosin—Thrombocytopenia—Valproic Acid—migraine	0.000389	0.00196	CcSEcCtD
Alfuzosin—Syncope—Timolol—migraine	0.000389	0.00196	CcSEcCtD
Alfuzosin—Tachycardia—Valproic Acid—migraine	0.000388	0.00195	CcSEcCtD
Alfuzosin—Vomiting—Propranolol—migraine	0.000387	0.00195	CcSEcCtD
Alfuzosin—Pharyngitis—Topiramate—migraine	0.000387	0.00195	CcSEcCtD
Alfuzosin—Skin disorder—Valproic Acid—migraine	0.000386	0.00194	CcSEcCtD
Alfuzosin—Urinary tract disorder—Topiramate—migraine	0.000385	0.00194	CcSEcCtD
Alfuzosin—Hyperhidrosis—Valproic Acid—migraine	0.000384	0.00193	CcSEcCtD
Alfuzosin—Rash—Propranolol—migraine	0.000384	0.00193	CcSEcCtD
Alfuzosin—Dermatitis—Propranolol—migraine	0.000384	0.00193	CcSEcCtD
Alfuzosin—Diarrhoea—Verapamil—migraine	0.000383	0.00193	CcSEcCtD
Alfuzosin—Connective tissue disorder—Topiramate—migraine	0.000383	0.00193	CcSEcCtD
Alfuzosin—Palpitations—Timolol—migraine	0.000383	0.00193	CcSEcCtD
Alfuzosin—Urethral disorder—Topiramate—migraine	0.000382	0.00192	CcSEcCtD
Alfuzosin—Loss of consciousness—Timolol—migraine	0.000381	0.00192	CcSEcCtD
Alfuzosin—Ill-defined disorder—Gabapentin—migraine	0.000374	0.00189	CcSEcCtD
Alfuzosin—Hypotension—Valproic Acid—migraine	0.000371	0.00187	CcSEcCtD
Alfuzosin—Dizziness—Verapamil—migraine	0.000371	0.00187	CcSEcCtD
Alfuzosin—Arthralgia—Timolol—migraine	0.000369	0.00186	CcSEcCtD
Alfuzosin—Chest pain—Timolol—migraine	0.000369	0.00186	CcSEcCtD
Alfuzosin—Angioedema—Gabapentin—migraine	0.000369	0.00186	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000366	0.00184	CcSEcCtD
Alfuzosin—Discomfort—Timolol—migraine	0.000365	0.00184	CcSEcCtD
Alfuzosin—Eye disorder—Topiramate—migraine	0.000364	0.00183	CcSEcCtD
Alfuzosin—Malaise—Gabapentin—migraine	0.000364	0.00183	CcSEcCtD
Alfuzosin—Vertigo—Gabapentin—migraine	0.000363	0.00183	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Valproic Acid—migraine	0.000362	0.00182	CcSEcCtD
Alfuzosin—Flushing—Topiramate—migraine	0.000362	0.00182	CcSEcCtD
Alfuzosin—Cardiac disorder—Topiramate—migraine	0.000362	0.00182	CcSEcCtD
Alfuzosin—Syncope—Gabapentin—migraine	0.000362	0.00182	CcSEcCtD
Alfuzosin—Nausea—Propranolol—migraine	0.000362	0.00182	CcSEcCtD
Alfuzosin—Dry mouth—Timolol—migraine	0.000361	0.00182	CcSEcCtD
Alfuzosin—Palpitations—Gabapentin—migraine	0.000357	0.0018	CcSEcCtD
Alfuzosin—Vomiting—Verapamil—migraine	0.000356	0.00179	CcSEcCtD
Alfuzosin—Loss of consciousness—Gabapentin—migraine	0.000355	0.00179	CcSEcCtD
Alfuzosin—Angiopathy—Topiramate—migraine	0.000354	0.00178	CcSEcCtD
Alfuzosin—Oedema—Timolol—migraine	0.000354	0.00178	CcSEcCtD
Alfuzosin—Rash—Verapamil—migraine	0.000353	0.00178	CcSEcCtD
Alfuzosin—Somnolence—Valproic Acid—migraine	0.000353	0.00178	CcSEcCtD
Alfuzosin—Dermatitis—Verapamil—migraine	0.000353	0.00178	CcSEcCtD
Alfuzosin—Mediastinal disorder—Topiramate—migraine	0.000352	0.00177	CcSEcCtD
Alfuzosin—Infection—Timolol—migraine	0.000351	0.00177	CcSEcCtD
Alfuzosin—Headache—Verapamil—migraine	0.000351	0.00177	CcSEcCtD
Alfuzosin—Dyspepsia—Valproic Acid—migraine	0.00035	0.00176	CcSEcCtD
Alfuzosin—Shock—Timolol—migraine	0.000348	0.00175	CcSEcCtD
Alfuzosin—Nervous system disorder—Timolol—migraine	0.000347	0.00175	CcSEcCtD
Alfuzosin—Arthralgia—Gabapentin—migraine	0.000344	0.00173	CcSEcCtD
Alfuzosin—Chest pain—Gabapentin—migraine	0.000344	0.00173	CcSEcCtD
Alfuzosin—Skin disorder—Timolol—migraine	0.000344	0.00173	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Valproic Acid—migraine	0.000343	0.00173	CcSEcCtD
Alfuzosin—Fatigue—Valproic Acid—migraine	0.000343	0.00172	CcSEcCtD
Alfuzosin—Hyperhidrosis—Timolol—migraine	0.000342	0.00172	CcSEcCtD
Alfuzosin—Mental disorder—Topiramate—migraine	0.000342	0.00172	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000341	0.00172	CcSEcCtD
Alfuzosin—Constipation—Valproic Acid—migraine	0.00034	0.00171	CcSEcCtD
Alfuzosin—Pain—Valproic Acid—migraine	0.00034	0.00171	CcSEcCtD
Alfuzosin—Discomfort—Gabapentin—migraine	0.000339	0.00171	CcSEcCtD
Alfuzosin—Dry mouth—Gabapentin—migraine	0.000336	0.00169	CcSEcCtD
Alfuzosin—Nausea—Verapamil—migraine	0.000333	0.00168	CcSEcCtD
Alfuzosin—ADRA1D—G alpha (q) signalling events—HTR2C—migraine	0.000333	0.00297	CbGpPWpGaD
Alfuzosin—Hypotension—Timolol—migraine	0.00033	0.00166	CcSEcCtD
Alfuzosin—Oedema—Gabapentin—migraine	0.000329	0.00166	CcSEcCtD
Alfuzosin—Back pain—Topiramate—migraine	0.000328	0.00165	CcSEcCtD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—HTR2A—migraine	0.000328	0.00293	CbGpPWpGaD
Alfuzosin—Feeling abnormal—Valproic Acid—migraine	0.000327	0.00165	CcSEcCtD
Alfuzosin—Infection—Gabapentin—migraine	0.000327	0.00165	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Valproic Acid—migraine	0.000325	0.00164	CcSEcCtD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000325	0.0029	CbGpPWpGaD
Alfuzosin—Shock—Gabapentin—migraine	0.000324	0.00163	CcSEcCtD
Alfuzosin—ADRA1D—G alpha (q) signalling events—EDNRA—migraine	0.000324	0.00289	CbGpPWpGaD
Alfuzosin—Nervous system disorder—Gabapentin—migraine	0.000323	0.00163	CcSEcCtD
Alfuzosin—Thrombocytopenia—Gabapentin—migraine	0.000322	0.00162	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Timolol—migraine	0.000322	0.00162	CcSEcCtD
Alfuzosin—Tachycardia—Gabapentin—migraine	0.000321	0.00162	CcSEcCtD
Alfuzosin—Skin disorder—Gabapentin—migraine	0.00032	0.00161	CcSEcCtD
Alfuzosin—ADRA1B—LPA receptor mediated events—FOS—migraine	0.00032	0.00285	CbGpPWpGaD
Alfuzosin—Hyperhidrosis—Gabapentin—migraine	0.000318	0.0016	CcSEcCtD
Alfuzosin—Urticaria—Valproic Acid—migraine	0.000316	0.00159	CcSEcCtD
Alfuzosin—Ill-defined disorder—Topiramate—migraine	0.000315	0.00159	CcSEcCtD
Alfuzosin—Somnolence—Timolol—migraine	0.000314	0.00158	CcSEcCtD
Alfuzosin—Abdominal pain—Valproic Acid—migraine	0.000314	0.00158	CcSEcCtD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000313	0.0028	CbGpPWpGaD
Alfuzosin—Dyspepsia—Timolol—migraine	0.000311	0.00157	CcSEcCtD
Alfuzosin—Hypotension—Gabapentin—migraine	0.000308	0.00155	CcSEcCtD
Alfuzosin—Malaise—Topiramate—migraine	0.000306	0.00154	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Timolol—migraine	0.000305	0.00154	CcSEcCtD
Alfuzosin—Vertigo—Topiramate—migraine	0.000305	0.00154	CcSEcCtD
Alfuzosin—Fatigue—Timolol—migraine	0.000305	0.00154	CcSEcCtD
Alfuzosin—Syncope—Topiramate—migraine	0.000304	0.00153	CcSEcCtD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000304	0.00271	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000304	0.00271	CbGpPWpGaD
Alfuzosin—Pain—Timolol—migraine	0.000302	0.00152	CcSEcCtD
Alfuzosin—ADRA1A—GPCR ligand binding—RAMP1—migraine	0.000302	0.0027	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CALCRL—migraine	0.000302	0.0027	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000302	0.0027	CbGpPWpGaD
Alfuzosin—Musculoskeletal discomfort—Gabapentin—migraine	0.0003	0.00151	CcSEcCtD
Alfuzosin—Palpitations—Topiramate—migraine	0.0003	0.00151	CcSEcCtD
Alfuzosin—Loss of consciousness—Topiramate—migraine	0.000298	0.0015	CcSEcCtD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR1D—migraine	0.000298	0.00266	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000298	0.00266	CbGpPWpGaD
Alfuzosin—Somnolence—Gabapentin—migraine	0.000293	0.00147	CcSEcCtD
Alfuzosin—Feeling abnormal—Timolol—migraine	0.000291	0.00147	CcSEcCtD
Alfuzosin—Dyspepsia—Gabapentin—migraine	0.00029	0.00146	CcSEcCtD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00029	0.00259	CbGpPWpGaD
Alfuzosin—Gastrointestinal pain—Timolol—migraine	0.000289	0.00146	CcSEcCtD
Alfuzosin—Arthralgia—Topiramate—migraine	0.000289	0.00146	CcSEcCtD
Alfuzosin—Chest pain—Topiramate—migraine	0.000289	0.00146	CcSEcCtD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000288	0.00258	CbGpPWpGaD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000287	0.00145	CcSEcCtD
Alfuzosin—Discomfort—Topiramate—migraine	0.000286	0.00144	CcSEcCtD
Alfuzosin—Asthenia—Valproic Acid—migraine	0.000285	0.00144	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Gabapentin—migraine	0.000284	0.00143	CcSEcCtD
Alfuzosin—Fatigue—Gabapentin—migraine	0.000284	0.00143	CcSEcCtD
Alfuzosin—Dry mouth—Topiramate—migraine	0.000283	0.00142	CcSEcCtD
Alfuzosin—Pain—Gabapentin—migraine	0.000282	0.00142	CcSEcCtD
Alfuzosin—Constipation—Gabapentin—migraine	0.000282	0.00142	CcSEcCtD
Alfuzosin—ADRA1B—G alpha (q) signalling events—NPS—migraine	0.000282	0.00252	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—TAC1—migraine	0.000282	0.00252	CbGpPWpGaD
Alfuzosin—Pruritus—Valproic Acid—migraine	0.000281	0.00142	CcSEcCtD
Alfuzosin—Urticaria—Timolol—migraine	0.000281	0.00141	CcSEcCtD
Alfuzosin—Abdominal pain—Timolol—migraine	0.00028	0.00141	CcSEcCtD
Alfuzosin—Oedema—Topiramate—migraine	0.000277	0.0014	CcSEcCtD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR2B—migraine	0.000277	0.00247	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000277	0.00247	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—HTR2C—migraine	0.000276	0.00247	CbGpPWpGaD
Alfuzosin—Infection—Topiramate—migraine	0.000275	0.00139	CcSEcCtD
Alfuzosin—Shock—Topiramate—migraine	0.000273	0.00137	CcSEcCtD
Alfuzosin—Diarrhoea—Valproic Acid—migraine	0.000272	0.00137	CcSEcCtD
Alfuzosin—Nervous system disorder—Topiramate—migraine	0.000272	0.00137	CcSEcCtD
Alfuzosin—Feeling abnormal—Gabapentin—migraine	0.000271	0.00137	CcSEcCtD
Alfuzosin—Thrombocytopenia—Topiramate—migraine	0.000271	0.00137	CcSEcCtD
Alfuzosin—Tachycardia—Topiramate—migraine	0.00027	0.00136	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Gabapentin—migraine	0.000269	0.00136	CcSEcCtD
Alfuzosin—Skin disorder—Topiramate—migraine	0.000269	0.00136	CcSEcCtD
Alfuzosin—ADRA1B—G alpha (q) signalling events—EDNRA—migraine	0.000269	0.0024	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000268	0.0024	CbGpPWpGaD
Alfuzosin—Hyperhidrosis—Topiramate—migraine	0.000268	0.00135	CcSEcCtD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000266	0.00238	CbGpPWpGaD
Alfuzosin—Dizziness—Valproic Acid—migraine	0.000263	0.00132	CcSEcCtD
Alfuzosin—Urticaria—Gabapentin—migraine	0.000262	0.00132	CcSEcCtD
Alfuzosin—Abdominal pain—Gabapentin—migraine	0.00026	0.00131	CcSEcCtD
Alfuzosin—Hypotension—Topiramate—migraine	0.000259	0.0013	CcSEcCtD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000257	0.0023	CbGpPWpGaD
Alfuzosin—Asthenia—Timolol—migraine	0.000254	0.00128	CcSEcCtD
Alfuzosin—Vomiting—Valproic Acid—migraine	0.000253	0.00127	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Topiramate—migraine	0.000252	0.00127	CcSEcCtD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000252	0.00225	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000252	0.00225	CbGpPWpGaD
Alfuzosin—Rash—Valproic Acid—migraine	0.000251	0.00126	CcSEcCtD
Alfuzosin—Dermatitis—Valproic Acid—migraine	0.00025	0.00126	CcSEcCtD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00025	0.00223	CbGpPWpGaD
Alfuzosin—Pruritus—Timolol—migraine	0.00025	0.00126	CcSEcCtD
Alfuzosin—ADRA1A—G alpha (q) signalling events—TAC1—migraine	0.00025	0.00223	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—NPS—migraine	0.00025	0.00223	CbGpPWpGaD
Alfuzosin—Headache—Valproic Acid—migraine	0.000249	0.00125	CcSEcCtD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR1D—migraine	0.000247	0.00221	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000247	0.00221	CbGpPWpGaD
Alfuzosin—Somnolence—Topiramate—migraine	0.000246	0.00124	CcSEcCtD
Alfuzosin—ADRA1A—G alpha (q) signalling events—HTR2C—migraine	0.000245	0.00219	CbGpPWpGaD
Alfuzosin—Dyspepsia—Topiramate—migraine	0.000244	0.00123	CcSEcCtD
Alfuzosin—Diarrhoea—Timolol—migraine	0.000242	0.00122	CcSEcCtD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00024	0.00215	CbGpPWpGaD
Alfuzosin—Gastrointestinal disorder—Topiramate—migraine	0.000239	0.0012	CcSEcCtD
Alfuzosin—Fatigue—Topiramate—migraine	0.000239	0.0012	CcSEcCtD
Alfuzosin—ADRA1A—G alpha (q) signalling events—EDNRA—migraine	0.000239	0.00213	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000237	0.00212	CbGpPWpGaD
Alfuzosin—Pain—Topiramate—migraine	0.000237	0.00119	CcSEcCtD
Alfuzosin—Constipation—Topiramate—migraine	0.000237	0.00119	CcSEcCtD
Alfuzosin—Asthenia—Gabapentin—migraine	0.000236	0.00119	CcSEcCtD
Alfuzosin—Nausea—Valproic Acid—migraine	0.000236	0.00119	CcSEcCtD
Alfuzosin—Dizziness—Timolol—migraine	0.000234	0.00118	CcSEcCtD
Alfuzosin—Pruritus—Gabapentin—migraine	0.000233	0.00117	CcSEcCtD
Alfuzosin—ADRA1D—GPCR downstream signaling—CALCRL—migraine	0.000232	0.00207	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—RAMP1—migraine	0.000232	0.00207	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR2B—migraine	0.00023	0.00205	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00023	0.00205	CbGpPWpGaD
Alfuzosin—Feeling abnormal—Topiramate—migraine	0.000228	0.00115	CcSEcCtD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000228	0.00204	CbGpPWpGaD
Alfuzosin—Gastrointestinal pain—Topiramate—migraine	0.000227	0.00114	CcSEcCtD
Alfuzosin—Diarrhoea—Gabapentin—migraine	0.000225	0.00113	CcSEcCtD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000225	0.00201	CbGpPWpGaD
Alfuzosin—Vomiting—Timolol—migraine	0.000225	0.00113	CcSEcCtD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000225	0.00201	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000225	0.00201	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000224	0.002	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000224	0.002	CbGpPWpGaD
Alfuzosin—Rash—Timolol—migraine	0.000223	0.00112	CcSEcCtD
Alfuzosin—Dermatitis—Timolol—migraine	0.000223	0.00112	CcSEcCtD
Alfuzosin—Headache—Timolol—migraine	0.000222	0.00112	CcSEcCtD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000221	0.00197	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00022	0.00197	CbGpPWpGaD
Alfuzosin—Urticaria—Topiramate—migraine	0.00022	0.00111	CcSEcCtD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR1D—migraine	0.00022	0.00196	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000219	0.00196	CbGpPWpGaD
Alfuzosin—Abdominal pain—Topiramate—migraine	0.000219	0.0011	CcSEcCtD
Alfuzosin—Dizziness—Gabapentin—migraine	0.000218	0.0011	CcSEcCtD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000214	0.00191	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000214	0.00191	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000213	0.00191	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—RAMP1—migraine	0.00021	0.00188	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CALCRL—migraine	0.00021	0.00188	CbGpPWpGaD
Alfuzosin—Nausea—Timolol—migraine	0.00021	0.00106	CcSEcCtD
Alfuzosin—Vomiting—Gabapentin—migraine	0.000209	0.00105	CcSEcCtD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000208	0.00185	CbGpPWpGaD
Alfuzosin—Rash—Gabapentin—migraine	0.000208	0.00105	CcSEcCtD
Alfuzosin—Dermatitis—Gabapentin—migraine	0.000207	0.00104	CcSEcCtD
Alfuzosin—Headache—Gabapentin—migraine	0.000206	0.00104	CcSEcCtD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR2B—migraine	0.000204	0.00182	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—HTR2A—migraine	0.000204	0.00182	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000204	0.00182	CbGpPWpGaD
Alfuzosin—Asthenia—Topiramate—migraine	0.000199	0.001	CcSEcCtD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000197	0.00176	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000196	0.00175	CbGpPWpGaD
Alfuzosin—Pruritus—Topiramate—migraine	0.000196	0.000987	CcSEcCtD
Alfuzosin—Nausea—Gabapentin—migraine	0.000196	0.000985	CcSEcCtD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000193	0.00172	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CALCRL—migraine	0.000192	0.00172	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—RAMP1—migraine	0.000192	0.00172	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00019	0.00169	CbGpPWpGaD
Alfuzosin—Diarrhoea—Topiramate—migraine	0.00019	0.000954	CcSEcCtD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000189	0.00169	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000187	0.00167	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000187	0.00167	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000187	0.00167	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000184	0.00165	CbGpPWpGaD
Alfuzosin—Dizziness—Topiramate—migraine	0.000183	0.000922	CcSEcCtD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000183	0.00163	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000183	0.00163	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR1B—migraine	0.000181	0.00161	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000178	0.00159	CbGpPWpGaD
Alfuzosin—Vomiting—Topiramate—migraine	0.000176	0.000887	CcSEcCtD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000175	0.00156	CbGpPWpGaD
Alfuzosin—Rash—Topiramate—migraine	0.000175	0.00088	CcSEcCtD
Alfuzosin—ADRA1B—Signaling by GPCR—RAMP1—migraine	0.000175	0.00156	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CALCRL—migraine	0.000175	0.00156	CbGpPWpGaD
Alfuzosin—Dermatitis—Topiramate—migraine	0.000175	0.000879	CcSEcCtD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR1A—migraine	0.000174	0.00155	CbGpPWpGaD
Alfuzosin—Headache—Topiramate—migraine	0.000174	0.000874	CcSEcCtD
Alfuzosin—ADRA1D—GPCR ligand binding—NPS—migraine	0.000171	0.00153	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—TAC1—migraine	0.000171	0.00153	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CALCRL—migraine	0.000171	0.00153	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—RAMP1—migraine	0.000171	0.00153	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—HTR2A—migraine	0.000169	0.00151	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR1D—migraine	0.000168	0.0015	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000168	0.0015	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR2C—migraine	0.000168	0.0015	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000166	0.00148	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000166	0.00148	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000166	0.00148	CbGpPWpGaD
Alfuzosin—Nausea—Topiramate—migraine	0.000165	0.000829	CcSEcCtD
Alfuzosin—ADRA1D—GPCR ligand binding—EDNRA—migraine	0.000163	0.00146	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000162	0.00145	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00016	0.00143	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000158	0.00141	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000158	0.00141	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CALCA—migraine	0.000157	0.0014	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR2B—migraine	0.000157	0.0014	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—RAMP1—migraine	0.000155	0.00139	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CALCRL—migraine	0.000155	0.00139	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR1D—migraine	0.000153	0.00137	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000152	0.00135	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—HTR2A—migraine	0.000151	0.00134	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR1B—migraine	0.00015	0.00134	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR7—migraine	0.000147	0.00131	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR1A—migraine	0.000144	0.00129	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000142	0.00127	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR2B—migraine	0.000142	0.00127	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—TAC1—migraine	0.000142	0.00127	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—NPS—migraine	0.000142	0.00127	CbGpPWpGaD
Alfuzosin—KCNH2—SIDS Susceptibility Pathways—TNF—migraine	0.000141	0.00126	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR1D—migraine	0.00014	0.00125	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR2C—migraine	0.000139	0.00124	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—EDNRA—migraine	0.000136	0.00121	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000135	0.00121	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000135	0.0012	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR1B—migraine	0.000133	0.00119	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000131	0.00117	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CALCA—migraine	0.00013	0.00116	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR2B—migraine	0.00013	0.00116	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR1A—migraine	0.000128	0.00114	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR1D—migraine	0.000127	0.00113	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—NPS—migraine	0.000126	0.00113	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—TAC1—migraine	0.000126	0.00113	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RAMP1—migraine	0.000124	0.00111	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CALCRL—migraine	0.000124	0.00111	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR1D—migraine	0.000124	0.00111	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR2C—migraine	0.000124	0.0011	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR7—migraine	0.000122	0.00109	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—EDNRA—migraine	0.00012	0.00107	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR2B—migraine	0.000118	0.00105	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000116	0.00104	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CALCA—migraine	0.000116	0.00103	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR2B—migraine	0.000115	0.00103	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR1D—migraine	0.000113	0.00101	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000112	0.001	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR7—migraine	0.000108	0.000968	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR2B—migraine	0.000105	0.000936	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RAMP1—migraine	0.000103	0.000922	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CALCRL—migraine	0.000103	0.000922	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—HTR2A—migraine	0.000103	0.000919	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR1B—migraine	0.000102	0.000911	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.97e-05	0.00089	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR1A—migraine	9.82e-05	0.000877	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—NPS—migraine	9.67e-05	0.000864	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—TAC1—migraine	9.67e-05	0.000864	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR2C—migraine	9.48e-05	0.000847	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR1B—migraine	9.26e-05	0.000827	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—EDNRA—migraine	9.23e-05	0.000824	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RAMP1—migraine	9.17e-05	0.000819	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CALCRL—migraine	9.17e-05	0.000819	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR1D—migraine	9.03e-05	0.000807	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR1A—migraine	8.92e-05	0.000796	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CALCA—migraine	8.88e-05	0.000793	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—TAC1—migraine	8.78e-05	0.000784	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—NPS—migraine	8.78e-05	0.000784	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR2C—migraine	8.61e-05	0.000769	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—HTR2A—migraine	8.55e-05	0.000763	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR1B—migraine	8.47e-05	0.000756	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2B—migraine	8.4e-05	0.00075	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—EDNRA—migraine	8.38e-05	0.000748	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR7—migraine	8.31e-05	0.000742	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR1A—migraine	8.15e-05	0.000728	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CALCA—migraine	8.07e-05	0.00072	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—NPS—migraine	8.03e-05	0.000717	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—TAC1—migraine	8.03e-05	0.000717	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR2C—migraine	7.87e-05	0.000703	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR1B—migraine	7.69e-05	0.000687	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—EDNRA—migraine	7.66e-05	0.000684	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—HTR2A—migraine	7.59e-05	0.000678	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR7—migraine	7.54e-05	0.000674	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR1B—migraine	7.52e-05	0.000672	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR1D—migraine	7.5e-05	0.00067	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR1A—migraine	7.4e-05	0.000661	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LRP1—migraine	7.39e-05	0.00066	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CALCA—migraine	7.37e-05	0.000658	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—TAC1—migraine	7.29e-05	0.000651	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—NPS—migraine	7.29e-05	0.000651	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR1A—migraine	7.24e-05	0.000647	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR2C—migraine	7.15e-05	0.000638	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—TAC1—migraine	7.13e-05	0.000637	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—NPS—migraine	7.13e-05	0.000637	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR2C—migraine	6.99e-05	0.000624	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2B—migraine	6.97e-05	0.000622	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—EDNRA—migraine	6.95e-05	0.000621	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR7—migraine	6.89e-05	0.000616	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR1B—migraine	6.83e-05	0.00061	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—EDNRA—migraine	6.8e-05	0.000607	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CALCA—migraine	6.69e-05	0.000598	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR1D—migraine	6.66e-05	0.000595	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR1A—migraine	6.57e-05	0.000587	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CALCA—migraine	6.55e-05	0.000585	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—TAC1—migraine	6.47e-05	0.000578	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—NPS—migraine	6.47e-05	0.000578	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR2C—migraine	6.35e-05	0.000567	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR7—migraine	6.26e-05	0.000559	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2B—migraine	6.19e-05	0.000553	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—EDNRA—migraine	6.18e-05	0.000552	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LRP1—migraine	6.14e-05	0.000548	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR7—migraine	6.12e-05	0.000547	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CALCA—migraine	5.95e-05	0.000531	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—HTR2A—migraine	5.82e-05	0.00052	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH4—migraine	5.67e-05	0.000507	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR7—migraine	5.56e-05	0.000497	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR1B—migraine	5.47e-05	0.000489	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LRP1—migraine	5.45e-05	0.000487	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—HTR2A—migraine	5.28e-05	0.000472	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR1A—migraine	5.27e-05	0.00047	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TAC1—migraine	5.19e-05	0.000463	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NPS—migraine	5.19e-05	0.000463	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PGR—migraine	5.19e-05	0.000463	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2C—migraine	5.09e-05	0.000454	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EDNRA—migraine	4.95e-05	0.000442	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—HTR2A—migraine	4.83e-05	0.000431	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH3—migraine	4.82e-05	0.000431	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CALCA—migraine	4.76e-05	0.000425	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH4—migraine	4.71e-05	0.00042	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR1B—migraine	4.54e-05	0.000406	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR7—migraine	4.46e-05	0.000398	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—HTR2A—migraine	4.39e-05	0.000392	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR1A—migraine	4.37e-05	0.00039	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NPS—migraine	4.31e-05	0.000385	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TAC1—migraine	4.31e-05	0.000385	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PGR—migraine	4.31e-05	0.000385	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—HTR2A—migraine	4.29e-05	0.000383	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2C—migraine	4.22e-05	0.000377	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH4—migraine	4.18e-05	0.000373	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EDNRA—migraine	4.11e-05	0.000367	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR1B—migraine	4.03e-05	0.00036	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH3—migraine	4e-05	0.000358	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CALCA—migraine	3.95e-05	0.000353	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—HTR2A—migraine	3.9e-05	0.000348	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR1A—migraine	3.88e-05	0.000347	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFBR2—migraine	3.84e-05	0.000343	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TAC1—migraine	3.82e-05	0.000342	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PGR—migraine	3.82e-05	0.000342	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NPS—migraine	3.82e-05	0.000342	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2C—migraine	3.75e-05	0.000335	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR7—migraine	3.7e-05	0.00033	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EDNRA—migraine	3.65e-05	0.000326	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH3—migraine	3.56e-05	0.000318	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CALCA—migraine	3.51e-05	0.000314	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CACNA1A—migraine	3.29e-05	0.000294	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR7—migraine	3.29e-05	0.000293	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFBR2—migraine	3.19e-05	0.000284	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2A—migraine	3.12e-05	0.000279	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFBR2—migraine	2.83e-05	0.000253	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ESR1—migraine	2.77e-05	0.000247	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2A—migraine	2.59e-05	0.000231	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2A—migraine	2.3e-05	0.000205	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ESR1—migraine	2.3e-05	0.000205	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ESR1—migraine	2.04e-05	0.000182	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTHFR—migraine	1.09e-05	9.71e-05	CbGpPWpGaD
